CXCL12 and breast carcinoma: The dimeric CXCL12 activates recruitment of β-arrestin 2 to CXCR4 and chemotaxis of CXCR4-expressing breast cancer cells, whereas the monomeric CXCL12 promotes the CXCR4 signaling through Gαi and Akt.